Mechanistic insight into TRIP13-catalyzed Mad2 structural transition and spindle checkpoint silencing.

Brulotte, Melissa L; Jeong, Byung-Cheon; Li, Faxiang; Li, Bing; Yu, Eric B; Wu, Qiong; Brautigam, Chad A; Yu, Hongtao et al. · Nat Commun · 2017

basic_science · Level V

Where this comes from

Abstract

The spindle checkpoint maintains genomic stability and prevents aneuploidy. Unattached kinetochores convert the latent open conformer of the checkpoint protein Mad2 (O-Mad2) to the active closed conformer (C-Mad2), bound to Cdc20. C-Mad2-Cdc20 is incorporated into the mitotic checkpoint complex (MCC), which inhibits the anaphase-promoting complex/cyclosome (APC/C). The C-Mad2-binding protein p31<sup>comet</sup> and the ATPase TRIP13 promote MCC disassembly and checkpoint silencing. Here, using nuclear magnetic resonance (NMR) spectroscopy, we show that TRIP13 and p31<sup>comet</sup> catalyze the conversion of C-Mad2 to O-Mad2, without disrupting its stably folded core. We determine the crystal structure of human TRIP13, and identify functional TRIP13 residues that mediate p31<sup>comet</sup>-Mad2 binding and couple ATP hydrolysis to local unfolding of Mad2. TRIP13 and p31<sup>comet</sup> prevent APC/C inhibition by MCC components, but cannot reactivate APC/C already bound to MCC. Therefore, TRIP13-p31<sup>comet</sup> intercepts and disassembles free MCC not bound to APC/C through mediating the local unfolding of the Mad2 C-terminal region.

Medical subject headings